U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 343

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr3:69168561-69168562
GRCh38:
Chr3:69119410-69119411
LMOD3L315fsNemaline myopathy 10Pathogenic
(May 8, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr3:69168088
GRCh38:
Chr3:69118937
LMOD3S473*Nemaline myopathy 10Likely pathogenic
(Feb 21, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr3:69171324
GRCh38:
Chr3:69122173
LMOD3, LOC126806710V72INemaline myopathy 10Uncertain significance
(Jan 10, 2019)
criteria provided, single submitter
4.
GRCh37:
Chr3:69168138
GRCh38:
Chr3:69118987
LMOD3N456KNemaline myopathy 10Uncertain significance
(Mar 7, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr3:69169038-69169039
GRCh38:
Chr3:69119887-69119888
LMOD3Nemaline myopathy 10Uncertain significance
(Aug 9, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr3:69167885
GRCh38:
Chr3:69118734
LMOD3D541NNemaline myopathy 10Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr3:69167977
GRCh38:
Chr3:69118826
LMOD3N510SNemaline myopathy 10Uncertain significance
(Jul 23, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr3:69171495
GRCh38:
Chr3:69122344
LMOD3, LOC126806710D15NNemaline myopathy 10Uncertain significance
(Apr 28, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr3:69171521
GRCh38:
Chr3:69122370
LMOD3, LOC126806710R6INemaline myopathy 10Uncertain significance
(Feb 18, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr3:69168170
GRCh38:
Chr3:69119019
LMOD3F446LInborn genetic diseases, Nemaline myopathy 10Uncertain significance
(Nov 18, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr3:69171250-69171260
GRCh38:
Chr3:69122099-69122109
LMOD3, LOC126806710T93fsNemaline myopathy 10Pathogenic
(Apr 4, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr3:69171266
GRCh38:
Chr3:69122115
LMOD3, LOC126806710P91LNemaline myopathy 10Uncertain significance
(Apr 11, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr3:69168623-69168624
GRCh38:
Chr3:69119472-69119473
LMOD3D295fsNemaline myopathy 10Pathogenic
(Mar 12, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr3:69168366
GRCh38:
Chr3:69119215
LMOD3Nemaline myopathy 10Likely benign
(Mar 14, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr3:69168176
GRCh38:
Chr3:69119025
LMOD3Q444*Nemaline myopathy 10Pathogenic
(Apr 19, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr3:69168516
GRCh38:
Chr3:69119365
LMOD3I330MNemaline myopathy 10Uncertain significance
(Jul 27, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr3:69171490
GRCh38:
Chr3:69122339
LMOD3, LOC126806710Nemaline myopathy 10Likely benign
(Sep 6, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr3:69167940
GRCh38:
Chr3:69118789
LMOD3Nemaline myopathy 10Likely benign
(Apr 4, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr3:69171426
GRCh38:
Chr3:69122275
LOC126806710, LMOD3E38*Nemaline myopathy 10Pathogenic
(Apr 6, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr3:69168151
GRCh38:
Chr3:69119000
LMOD3P452RNemaline myopathy 10Uncertain significance
(Apr 3, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr3:69168526
GRCh38:
Chr3:69119375
LMOD3I327TNemaline myopathy 10Uncertain significance
(May 22, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr3:69168516
GRCh38:
Chr3:69119365
LMOD3Nemaline myopathy 10Likely benign
(Mar 4, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr3:69169194
GRCh38:
Chr3:69120043
LMOD3Nemaline myopathy 10Likely benign
(Mar 1, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr3:69168943
GRCh38:
Chr3:69119792
LMOD3C188YNemaline myopathy 10Uncertain significance
(Oct 17, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr3:69167838
GRCh38:
Chr3:69118687
LMOD3Nemaline myopathy 10Uncertain significance
(Feb 8, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr3:69167899
GRCh38:
Chr3:69118748
LMOD3D536VNemaline myopathy 10Uncertain significance
(Jul 11, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr3:69168188
GRCh38:
Chr3:69119037
LMOD3D440NNemaline myopathy 10Uncertain significance
(Jan 18, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr3:69169076
GRCh38:
Chr3:69119925
LMOD3D144NNemaline myopathy 10Uncertain significance
(Jul 21, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr3:69168999
GRCh38:
Chr3:69119848
LMOD3Nemaline myopathy 10Likely benign
(Aug 10, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr3:69169136
GRCh38:
Chr3:69119985
LMOD3N124DNemaline myopathy 10Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr3:69171422
GRCh38:
Chr3:69122271
LMOD3, LOC126806710M39TNemaline myopathy 10Uncertain significance
(Mar 1, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr3:69168959
GRCh38:
Chr3:69119808
LMOD3N183DNemaline myopathy 10Uncertain significance
(Aug 15, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr3:69158249
GRCh38:
Chr3:69109098
LMOD3Nemaline myopathy 10Likely benign
(Mar 18, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr3:69171401
GRCh38:
Chr3:69122250
LMOD3, LOC126806710P46LNemaline myopathy 10Uncertain significance
(Jun 6, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr3:69168254
GRCh38:
Chr3:69119103
LMOD3A418TNemaline myopathy 10Uncertain significance
(Jun 10, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr3:69168454
GRCh38:
Chr3:69119303
LMOD3M351TNemaline myopathy 10Uncertain significance
(May 20, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr3:69171442
GRCh38:
Chr3:69122291
LMOD3, LOC126806710Nemaline myopathy 10Likely benign
(Oct 20, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr3:69168125
GRCh38:
Chr3:69118974
LMOD3P461SNemaline myopathy 10Uncertain significance
(Oct 4, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr3:69169231
GRCh38:
Chr3:69120080
LMOD3Nemaline myopathy 10Likely benign
(Oct 8, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr3:69168210
GRCh38:
Chr3:69119059
LMOD3Nemaline myopathy 10Likely benign
(Aug 31, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr3:69168418
GRCh38:
Chr3:69119267
LMOD3L363RNemaline myopathy 10Uncertain significance
(Oct 1, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr3:69171312
GRCh38:
Chr3:69122161
LMOD3, LOC126806710Y76HNemaline myopathy 10Uncertain significance
(Jul 9, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr3:69168348
GRCh38:
Chr3:69119197
LMOD3Nemaline myopathy 10Likely benign
(Jul 13, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr3:69158262
GRCh38:
Chr3:69109111
LMOD3P556RNemaline myopathy 10Uncertain significance
(Jun 25, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr3:69168450
GRCh38:
Chr3:69119299
LMOD3Nemaline myopathy 10Likely benign
(May 20, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr3:69168634
GRCh38:
Chr3:69119483
LMOD3N291TNemaline myopathy 10Uncertain significance
(May 27, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr3:69168238
GRCh38:
Chr3:69119087
LMOD3G423ANemaline myopathy 10Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr3:69168014
GRCh38:
Chr3:69118863
LMOD3R498WNemaline myopathy 10Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr3:69169032
GRCh38:
Chr3:69119881
LMOD3E158DNemaline myopathy 10Uncertain significance
(Jun 14, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr3:69167955
GRCh38:
Chr3:69118804
LMOD3Nemaline myopathy 10Likely benign
(Feb 11, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr3:69168865
GRCh38:
Chr3:69119714
LMOD3S214LNemaline myopathy 10Uncertain significance
(May 16, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr3:69169041
GRCh38:
Chr3:69119890
LMOD3Nemaline myopathy 10Likely benign
(Oct 24, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr3:69171224
GRCh38:
Chr3:69122073
LMOD3, LOC126806710Nemaline myopathy 10Likely benign
(Jul 23, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr3:69168194
GRCh38:
Chr3:69119043
LMOD3K438ENemaline myopathy 10Uncertain significance
(Mar 8, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr3:69168873
GRCh38:
Chr3:69119722
LMOD3K211NNemaline myopathy 10Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr3:69169199
GRCh38:
Chr3:69120048
LMOD3E103KNemaline myopathy 10Uncertain significance
(May 12, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr3:69168521
GRCh38:
Chr3:69119370
LMOD3A329TNemaline myopathy 10Uncertain significance
(Aug 8, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr3:69171512
GRCh38:
Chr3:69122361
LMOD3, LOC126806710D9GNemaline myopathy 10Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr3:69168057
GRCh38:
Chr3:69118906
LMOD3Nemaline myopathy 10Likely benign
(Jul 14, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr3:69171262
GRCh38:
Chr3:69122111
LMOD3, LOC126806710Nemaline myopathy 10Likely benign
(Jan 12, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr3:69169089
GRCh38:
Chr3:69119938
LMOD3Nemaline myopathy 10Likely benign
(Apr 24, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr3:69168153
GRCh38:
Chr3:69119002
LMOD3Nemaline myopathy 10Likely benign
(Apr 30, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr3:69167979
GRCh38:
Chr3:69118828
LMOD3Nemaline myopathy 10Likely benign
(Aug 9, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr3:69158249
GRCh38:
Chr3:69109098
LMOD3Nemaline myopathy 10Likely benign
(Sep 6, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr3:69168411
GRCh38:
Chr3:69119260
LMOD3Nemaline myopathy 10Likely benign
(Feb 4, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr3:69171227
GRCh38:
Chr3:69122076
LMOD3, LOC126806710Nemaline myopathy 10Likely benign
(Oct 30, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr3:69168984
GRCh38:
Chr3:69119833
LMOD3Nemaline myopathy 10Likely benign
(Feb 22, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr3:69169047
GRCh38:
Chr3:69119896
LMOD3Nemaline myopathy 10Likely benign
(Mar 8, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr3:69158286
GRCh38:
Chr3:69109135
LMOD3Nemaline myopathy 10Benign
(Oct 21, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr3:69168260
GRCh38:
Chr3:69119109
LMOD3Nemaline myopathy 10Likely benign
(Aug 16, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr3:69171229
GRCh38:
Chr3:69122078
LMOD3, LOC126806710Nemaline myopathy 10Likely benign
(Nov 1, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr3:69168168
GRCh38:
Chr3:69119017
LMOD3Nemaline myopathy 10Likely benign
(May 17, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr3:69168090
GRCh38:
Chr3:69118939
LMOD3Nemaline myopathy 10Likely benign
(Oct 30, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr3:69169215
GRCh38:
Chr3:69120064
LMOD3Nemaline myopathy 10Likely benign
(Apr 6, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr3:69171495
GRCh38:
Chr3:69122344
LMOD3, LOC126806710D15HNemaline myopathy 10Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr3:69168674
GRCh38:
Chr3:69119523
LMOD3M278VNemaline myopathy 10Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr3:69171275
GRCh38:
Chr3:69122124
LOC126806710, LMOD3E88VNemaline myopathy 10Uncertain significance
(Jun 27, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr3:69168811
GRCh38:
Chr3:69119660
LMOD3T232INemaline myopathy 10Uncertain significance
(Aug 19, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr3:69169114
GRCh38:
Chr3:69119963
LMOD3K131RNemaline myopathy 10Uncertain significance
(Jun 27, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr3:69169216
GRCh38:
Chr3:69120065
LMOD3Nemaline myopathy 10Likely benign
(Oct 18, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr3:69169093
GRCh38:
Chr3:69119942
LMOD3S138NNemaline myopathy 10Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr3:69169011
GRCh38:
Chr3:69119860
LMOD3E165DInborn genetic diseases, Nemaline myopathy 10Uncertain significance
(Mar 17, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr3:69168151
GRCh38:
Chr3:69119000
LMOD3P452LNemaline myopathy 10Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr3:69167913
GRCh38:
Chr3:69118762
LMOD3E531DNemaline myopathy 10, Inborn genetic diseasesUncertain significance
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr3:69168346
GRCh38:
Chr3:69119195
LMOD3T387INemaline myopathy 10Uncertain significance
(Nov 22, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr3:69168376
GRCh38:
Chr3:69119225
LMOD3F377SNemaline myopathy 10, Inborn genetic diseasesUncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr3:69168683
GRCh38:
Chr3:69119532
LMOD3V275INemaline myopathy 10Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr3:69167864
GRCh38:
Chr3:69118713
LMOD3A548TNemaline myopathy 10Uncertain significance
(Mar 25, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr3:69168031-69168033
GRCh38:
Chr3:69118880-69118882
LMOD3R492delNemaline myopathy 10Uncertain significance
(Aug 3, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr3:69168057
GRCh38:
Chr3:69118906
LMOD3D483ENemaline myopathy 10Uncertain significance
(Aug 26, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr3:69168272
GRCh38:
Chr3:69119121
LMOD3E412KNemaline myopathy 10Uncertain significance
(Aug 26, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr3:69171308
GRCh38:
Chr3:69122157
LOC126806710, LMOD3W77LNemaline myopathy 10Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr3:69167878
GRCh38:
Chr3:69118727
LMOD3R543HInborn genetic diseases, Nemaline myopathy 10Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr3:69167849
GRCh38:
Chr3:69118698
LMOD3Nemaline myopathy 10Uncertain significance
(Aug 18, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr3:69168729
GRCh38:
Chr3:69119578
LMOD3N259KNemaline myopathy 10Uncertain significance
(Aug 7, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr3:69167966
GRCh38:
Chr3:69118815
LMOD3V514INemaline myopathy 10Uncertain significance
(Jun 20, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr3:69169045
GRCh38:
Chr3:69119894
LMOD3D154GNemaline myopathy 10, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Nov 5, 2021)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr3:69171443-69171458
GRCh38:
Chr3:69122292-69122307
LMOD3, LOC126806710Nemaline myopathy 10Pathogenic
(Oct 28, 2020)
criteria provided, single submitter
99.
GRCh37:
Chr3:69168287
GRCh38:
Chr3:69119136
LMOD3Q407*Nemaline myopathy 10Pathogenic
(Aug 19, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr3:69168802
GRCh38:
Chr3:69119651
LMOD3S235*Nemaline myopathy 10Pathogenic
(Sep 9, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination